Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

The association between chemerin and homeostasis assessment of insulin resistance at baseline and after weight reduction via lifestyle modifications in young obese adults.

Lee MK, Chu SH, Lee DC, An KY, Park JH, Kim DI, Kim J, Hong S, Im JA, Lee JW, Jeon JY.

Clin Chim Acta. 2013 Jun 5;421:109-15. doi: 10.1016/j.cca.2013.02.017. Epub 2013 Feb 26.

PMID:
23485648
2.

Effect of lifestyle modification on serum chemerin concentration and its association with insulin sensitivity in overweight and obese adults with type 2 diabetes.

Kim SH, Lee SH, Ahn KY, Lee DH, Suh YJ, Cho SG, Choi YJ, Lee DH, Lee SY, Hong SB, Kim YS, Jeon JY, Nam M.

Clin Endocrinol (Oxf). 2014 Jun;80(6):825-33. doi: 10.1111/cen.12249. Epub 2013 Jun 20.

PMID:
23682797
3.

Differential patterns of serum concentration and adipose tissue expression of chemerin in obesity: adipose depot specificity and gender dimorphism.

Alfadda AA, Sallam RM, Chishti MA, Moustafa AS, Fatma S, Alomaim WS, Al-Naami MY, Bassas AF, Chrousos GP, Jo H.

Mol Cells. 2012 Jun;33(6):591-6. doi: 10.1007/s10059-012-0012-7. Epub 2012 Apr 27.

4.

Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity.

Chakaroun R, Raschpichler M, Klöting N, Oberbach A, Flehmig G, Kern M, Schön MR, Shang E, Lohmann T, Dreßler M, Fasshauer M, Stumvoll M, Blüher M.

Metabolism. 2012 May;61(5):706-14. doi: 10.1016/j.metabol.2011.10.008. Epub 2011 Dec 2.

PMID:
22136911
5.

Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults.

Neeland IJ, Ayers CR, Rohatgi AK, Turer AT, Berry JD, Das SR, Vega GL, Khera A, McGuire DK, Grundy SM, de Lemos JA.

Obesity (Silver Spring). 2013 Sep;21(9):E439-47. doi: 10.1002/oby.20135. Epub 2013 May 19.

6.

Circulating chemerin level is independently correlated with arterial stiffness.

Yoo HJ, Choi HY, Yang SJ, Kim HY, Seo JA, Kim SG, Kim NH, Choi KM, Choi DS, Baik SH.

J Atheroscler Thromb. 2012;19(1):59-66; discussion 67-8. Epub 2011 Nov 21.

7.

[Relationship of serum Chemerin to obesity and type 2 diabetes mellitus].

Wang LY, Wei L, Yu HY, Zhang Y, Jia WP.

Zhonghua Yi Xue Za Zhi. 2009 Feb 3;89(4):235-8. Chinese.

PMID:
19552838
8.

Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons.

Vogeser M, König D, Frey I, Predel HG, Parhofer KG, Berg A.

Clin Biochem. 2007 Sep;40(13-14):964-8. Epub 2007 Jun 2.

PMID:
17583689
9.

Exercise-induced lowering of chemerin is associated with reduced cardiometabolic risk and glucose-stimulated insulin secretion in older adults.

Malin SK, Navaneethan SD, Mulya A, Huang H, Kirwan JP.

J Nutr Health Aging. 2014;18(6):608-15. doi: 10.1007/s12603-014-0459-7.

10.

Obesity indices and metabolic markers are related to hs-CRP and adiponectin levels in overweight and obese females.

Sanip Z, Ariffin FD, Al-Tahami BA, Sulaiman WA, Rasool AH.

Obes Res Clin Pract. 2013 Jul-Aug;7(4):e315-20. doi: 10.1016/j.orcp.2012.05.002.

PMID:
24306161
11.

Circulating chemerin decreases in response to a combined strength and endurance training.

Stefanov T, Blüher M, Vekova A, Bonova I, Tzvetkov S, Kurktschiev D, Temelkova-Kurktschiev T.

Endocrine. 2014 Apr;45(3):382-91. doi: 10.1007/s12020-013-0003-2. Epub 2013 Jun 20.

PMID:
23783366
12.

Long-term interdisciplinary therapy reduces endotoxin level and insulin resistance in obese adolescents.

Lira FS, Rosa JC, Pimentel GD, Santos RV, Carnier J, Sanches PL, de Piano A, de Souza CT, Tock L, Tufik S, de Mello MT, Seelaender M, Oller do Nascimento CM, Oyama LM, Dâmaso AR.

Nutr J. 2012 Sep 18;11:74. doi: 10.1186/1475-2891-11-74.

13.

Insulin-sensitive obesity.

Klöting N, Fasshauer M, Dietrich A, Kovacs P, Schön MR, Kern M, Stumvoll M, Blüher M.

Am J Physiol Endocrinol Metab. 2010 Sep;299(3):E506-15. doi: 10.1152/ajpendo.00586.2009. Epub 2010 Jun 22.

14.

Associations of visceral adiposity and exercise participation with C-reactive protein, insulin resistance, and endothelial dysfunction in Korean healthy adults.

Kim K, Valentine RJ, Shin Y, Gong K.

Metabolism. 2008 Sep;57(9):1181-9. doi: 10.1016/j.metabol.2008.04.009.

PMID:
18702942
15.

Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance.

Makino S, Handa H, Suzukawa K, Fujiwara M, Nakamura M, Muraoka S, Takasago I, Tanaka Y, Hashimoto K, Sugimoto T.

Clin Endocrinol (Oxf). 2006 Jan;64(1):12-9.

PMID:
16402923
16.

Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery.

Sell H, Divoux A, Poitou C, Basdevant A, Bouillot JL, Bedossa P, Tordjman J, Eckel J, Clément K.

J Clin Endocrinol Metab. 2010 Jun;95(6):2892-6. doi: 10.1210/jc.2009-2374. Epub 2010 Apr 7.

PMID:
20375212
17.

Effect of exercise on circulating adipokine levels in obese young women.

Kondo T, Kobayashi I, Murakami M.

Endocr J. 2006 Apr;53(2):189-95.

18.

Subcutaneous and total fat at L4-L5 and subcutaneous, visceral and total fat at L3-L4 are important contributors of fasting and postprandial adiponectin levels.

Katergari SA, Passadakis P, Milousis A, Passadaki T, Asimakopoulos B, Mantatzis M, Prassopoulos P, Tripsianis G, Nikolettos N, Papachristou DN.

Endocr Res. 2015;40(3):127-32. doi: 10.3109/07435800.2014.920349. Epub 2015 Mar 16.

PMID:
25774471
19.

The increase of serum chemerin concentration is mainly associated with the increase of body mass index in obese, non-diabetic subjects.

Sledzinski T, Korczynska J, Hallmann A, Kaska L, Proczko-Markuszewska M, Stefaniak T, Sledzinski M, Swierczynski J.

J Endocrinol Invest. 2013 Jun;36(6):428-34. doi: 10.3275/8770. Epub 2012 Nov 27.

PMID:
23211604
20.
Items per page

Supplemental Content

Write to the Help Desk